News
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
OptumRx, a pharmacy benefit manager accused in hundreds of lawsuits of contributing to the opioid crisis, sued five Kentucky ...
Complete UnitedHealth Group Inc. stock information by Barron's. View real-time UNH stock price and news, along with industry-best analysis.
Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results